Rapid advances made using genomic approaches, molecular analysis using immunohistochemistry, measurement of proliferative capacity, and gene expression profiles have allowed the further categorization of breast cancers into four types; these are the luminal A, luminal B, HER2 and basal-like subtypes [3–6]. This evidence concerns the gene ERBB2 and breast carcinoma.